This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Researchers at Pohang University of Science and Technology (POSTECH), South Korea, have developed a super-photostable organic dye. The discovery sets a new benchmark for organic fluorophores, Professor Young-Tae Chang explained, providing potential applications in broad areas such as drug development and cellular imaging. Single-molecule imaging uses fluorescent markers to track proteins with precision.
Introduction In todays fast-paced world, pharma digital marketing is more than just a strategyit’s a necessity. With increasing competition, strict regulations, and changing consumer behavior, pharmaceutical brands must embrace digital transformation to stay relevant. But how can pharma marketers break through the noise, engage their audience, and see real ROI?
Biotech venture capital is on the precipice of a generational shift. At least, that’s according to the crowd of younger firm founders edging their way in. There’s long been a small batch of scientists and business leaders who invest in drug companies. For the first 15 years of the 21st century, you’d find only 400, maybe 450 VC firms regularly giving money to drug startups — biotech’s own version of The Four Hundred , with lab coats or branded polar fleece, rat
The American Conference Institutes popular FDA Boot Camp now in its 43rd iteration is scheduled to take place from March 19-20, 2025, at the NY Bar Association in New York, NY. The conference is billed as the premier event to provide folks with a roadmap to navigate the difficult terrain of FDA regulatory law. And it is exactly that! The conference equips legal professionals without prior regulatory experience, as well as life sciences executives involved with FDA-regulated products, with a
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
In 2019, amid a measles outbreak in New York, federal health officials uniformly preached the power of immunizations. “Measles is preventable and the way to end this outbreak is to ensure that all children and adults who can get vaccinated, do get vaccinated,” said Robert Redfield , then the director of the Centers for Disease Control and Prevention.
By Julie Kim & Deborah L. Livornese As anticipated, the International Council for Harmonization (ICH) published the Good Clinical Practice (GCP) guideline E6(R3) Principles and Annex 1 on January 6, 2025. While ICH E6(R3) was still in the development phase, the FDA released a draft guidance in May 2023 in the form of the draft ICH E6(R3). No word yet on whether FDA will issue guidance endorsing the final ICH E6(R3).
The public and pharmaceutical companies are calling for changes in drug regulation and the costs of medicines. They are right to do so. Companies want to see products approved faster for financial reasons, and patients want medicines that can improve their lives. The two are inextricably tied, and realizing those goals requires tossing out the broken system we have in exchange for a superior system that is richer in data and evidence.
The public and pharmaceutical companies are calling for changes in drug regulation and the costs of medicines. They are right to do so. Companies want to see products approved faster for financial reasons, and patients want medicines that can improve their lives. The two are inextricably tied, and realizing those goals requires tossing out the broken system we have in exchange for a superior system that is richer in data and evidence.
As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.
Federal health officials due to speak at the Healthcare Information and Management Systems Society meeting in Las Vegas next week have dropped out of the key health tech industry conference. Even as the Trump administration focuses on fraud, waste, and abuse, government officials aren’t allowed to tell the public about their programs aimed at preventing fraud, waste, and misuse in Medicare telehealth and remote patient monitoring programs.
Researchers conducted a cross-sectional study to investigate the accessibility of over-the-counter naloxone and nonprescription syringes at community pharmacies.
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Health care investor Kevin Tang buys “zombie” biotechs to shut them down. It’s a counterintuitive, but ingenious solution to the sector’s intractable problem covered in last week’s newsletter.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The announcement comes after the FDA declared the shortage of semaglutide (Ozempic, Wegovy) has been resolved after being in shortage since March 2022.
Pfizer on Thursday made significant changes to its diversity, equity, and inclusion webpage , as companies across different industries seek to reposition their policies and messaging amid President Trump’s dismantling of DEI initiatives. The pharma company now emphasizes merit throughout its webpage. Pfizer has changed the title of the page from “Diversity, Equity, and Inclusion” to “Merit-Based Diversity, Equity, and Inclusion,” and added a sentence to its int
Authors of a research letter published in JAMA said that the decrease in glycemic control may be due to consequences of the COVID-19 pandemic, such as sedentary behavior and increased mental health stressors.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Can you believe the temperature in Boston hit the 50s yesterday? It’s the first false start to spring, and I’m sure that there are more cold days ahead of us. But still, it was so, so sweet.
A new report by nonprofit Phyx Primary Care finds that physicians feel more satisfied with their work and less burned out when supported by an ambient AI scribe.
Congress is poised to approve steep cuts to the Medicaid program, and multiple new studies seek to analyze the impact that significant changes could have on states and enrollees.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
SPI-1005, a novel anti-inflammatory compound, achieved coprimary end points for efficacy, including improvements in hearing loss and speech discrimination.
A rumored private equity buyout of Walgreens could lead the company to be split up, according to media reports. | A rumored private equity buyout of Walgreens could lead the company to be split up, according to media reports.
Compared with other indicators of cardiovascular risk, the ratio of non-high-density lipoprotein cholesterol (HDL-C) to normal HDL-C had a stronger association with the risk of hypertension and heart disease.
Athenahealth will offer Abridge's ambient clinical documentation solution as part of its growing suite of artificial intelligence tools for small and independent provider practices. | Abridge will join Suki and iScribe in athenahealth's suite of ambient AI tools for clinical documentation.
Discover how digital health technologies and collaboration are driving innovation in the field of rare diseases. Learn more about the latest advancements and how they are improving patient outcomes and access to care.
UK pharmaceutical companies aim to put executive pay on par with US rivals but package will depend on share price Business live latest updates GSKs chief executive could take home nearly 22m this year as the pharmaceutical company attempts to offer US-style pay packets to top executives. Emma Walmsleys pay package will reach a maximum of 21.56m if the companys share price rises by 50%, according to its annual report.
Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft demand for gene therapies among haemophilia patients and physicians.
Panelists explain how health care professionals evaluate menopause symptoms using validated questionnaires, symptom tracking, clinical interviews, hormonal tests, and patient-reported outcome measures to comprehensively assess severity and quality-of-life impact.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content